SUMMARY The pharmacokinetics and clinical efficacy of amoxycillin combined with clavulanic acid in the treatment of 32 children with urinary tract infection were studied. Twenty one (80%) of 26 children with proved urinary tract infection showed a favourable clinical and bacteriological response. Fifteen of these children had amoxycillin resistant organisms and were treated successfully. In 20 children the serum and urine concentrations of amoxycillin and clavulanic acid were measured after the first oral dose. Pharmacokinetic studies were performed in 20 children. Dispersible tablets were used in 9 patients and 11 patients received the paediatric suspensions, (C2 in 6 patients and C4 in 5 patients). The first oral dose was given after a 4 to 8 hour fast. Blood
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Bacterial resistance to commonly used antibiotics which have a t6 lactam ring in their structure, such as the penicillins and the cephalosporins, is a considerable problem. Production of f lactamases, enzymes that hydrolyse these antibiotics, is one of the major ways in which bacteria acquire resistance. Sensitive organisms may acquire the ability to synthesise these enzymes and thus become resistant by transfer of an extrachromosomal plasmid that specifies i lactamase. Another method of acquiring resistance is chromosomal mediation in the bacterial strain.'
There are two ways to combat this problemfirstly to Tables 3 and 4 . The peak serum concentrations for both amoxycillin and clavulanic acid occurred between 30 and 90 minutes after the oral administration of the tablets and the paediatric suspension-C2 tablets, mean (SD); amoxycillin 6-8 (5-3) mg/l, clavulanic acid 3-4 (3.2) mg/l: C2 suspension mean (SD); amoxycillin 9.7 (7) mg/l, clavulanic acid 4-4 (3-8) mg/l. In those taking C4 suspension, the serum concentrations were highest at 90 minutes (amoxycillin mean (SD); 7-5 Clavulanic acid (31-75 mg) 0-9 (0-7) (0-2-0) 3-1 (1.7) (0(4-5.6) 3-7 (1-9) (0.5-5.6) (5.7) mg/I, clavulanic acid 3-7 (1-9) mg/i), but because of the timing of specimens the exact time of peak concentration could not be determined. High urinary concentrations of both drugs were maintained throughout the 0 to 6 hours collection period in all patients. Peak urinary concentrations were reached at between 2 and 4 hours for the three preparations (tablets: amoxycillin 225 (204) mg/l, clavulanic acid 53 (91) mg/I; C2 suspension: amoxycillin 205 (139) mg/I, clavulanic acid 57 3 (83) mg/I; C4 suspension: amoxycillin 620 (24) mg/I, clavulanic acid 103 (27) mg/i). The mean urinary excretions from 0 to 6 hours (% of dose given) were 53% and 32% for amoxycillin and clavulanic acid respectively in the tablet group' 14% and 9% for C2, and 37%
and 8% for C4 in the suspension group.
Discussion
The results of the clinical study showed that amoxycillin and clavulanic acid in combination were effective in 80% of those children with proved urinary tract infections. Bacteriological studies showed that most of these infections were caused by E coli (81%), which is similar to the incidence found in other studies of preschool children with urinary tract infections. In conclusion, the combination of amoxycillin and clavulanic acid was effective, safe, and well tolerated in all the age groups studied. Good therapeutic concentrations in serum and urine were achieved in the children over the age of 5 years, using a dose of amoxycillin 125 mg and clavulanic acid 62-5 mg (ratio 2:2).
Because of uncertainty about the metabolism of clavulanate by the immature kidney, the younger children in this study were given the combination of amoxycillin and clavulanic acid in the ratio of 4:1. The results obtained indicate, however, that a ratio of 2:1 would be satisfactory in children of all ages. the treatment of urinary infection. 
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